Recurrent HeartMate 3 Right Ventricular Assist Device Stoppages in a Biventricular Assist Device Carrier

Authors

  • Hrvoje Gasparovic, MD, Ph University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Center Zagreb, Zagreb, Croatia
  • Tomislav Tokic, MD University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Center Zagreb, Zagreb, Croatia
  • Maja Cikes, MD, PhD University of Zagreb School of Medicine, Department of Cardiovascular Diseases, University Hospital Center Zagreb, Zagreb, Croatia
  • Marjan Urlic, MD University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Center Zagreb, Zagreb, Croatia
  • Tomislav Kopjar, MD, PhD University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Center Zagreb, Zagreb, Croatia
  • Petra Cerina, MD University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Center Zagreb, Zagreb, Croatia
  • Ivan Knezevic, MD, PhD Department of Cardiac Surgery, University Hospital Center Ljubljana, Ljubljana, Slovenia
  • Drazen Perkov, MD, PhD University of Zagreb School of Medicine, Department of Radiology, University Hospital Center Zagreb, Zagreb, Croatia
  • Davor Milicic, MD, PhD University of Zagreb School of Medicine, Department of Cardiovascular Diseases, University Hospital Center Zagreb, Zagreb, Croatia
  • Bojan Biocina, MD, PhD University of Zagreb School of Medicine, Department of Cardiac Surgery, University Hospital Center Zagreb, Zagreb, Croatia

DOI:

https://doi.org/10.1532/hsf.5165

Keywords:

thrombosis, heartmate right ventricular assist device

Abstract

A 44-year-old female patient with chemotherapy-induced cardiomyopathy presented with acute cardiogenic shock requiring ECMO support. Multiple failed weaning trials from temporary mechanical circulatory assistance prompted a transition to staged durable biventricular support. Her course was complicated with recurrent RVAD stoppages. The initial event was treated with pump exchange, while for the subsequent RVAD standstill, we employed a device wash-out and reimplantation strategy. A brief period of circulatory arrest was employed to explore the right-sided cardiac chambers using a single-use bronchoscope.

References

Bellavia D, Iacovoni A, Scardulla C, et al. 2017. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail. 19:926-946.

Iyengar A, Atluri P. 2019. Commentary: You are what you eat-Pump thrombosis and device exchange of a HeartMate 3. J Thorac Cardiovasc Surg. 158:e41-e42.

Massicotte P, Snyder T, Stulak J, et al. 2017. Ventricular assist device thrombosis: Mind your P's &Q's-Pumps, patients, and pills. J Thorac Cardiovasc Surg. 153:1503-1506.

Mehra MR, Uriel N, Naka Y, et al. MOMENTUM 3 Investigators. 2019. A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 380:1618-1627.

Published

2023-01-31

How to Cite

Gasparovic, H., Tokic, T., Cikes, M., Urlic, M., Kopjar, T., Cerina, P., Knezevic, I., Perkov, D., Milicic, D., & Biocina, B. (2023). Recurrent HeartMate 3 Right Ventricular Assist Device Stoppages in a Biventricular Assist Device Carrier. The Heart Surgery Forum, 26(1), E038-E039. https://doi.org/10.1532/hsf.5165

Issue

Vol. 26 No. 1 (2023)

Section

Article
Author Disclosure & Copyright Transfer Agreement